Leptin and Lipid Profile in Overweight Patient with Type 1 Diabetes by Abd El Dayem, Soha M. et al.
  
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Apr 15; 5(2):131-136.                                                                                                                                                         131 
 
ID Design 2012/DOOEL Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2017 Apr 15; 5(2):131-136. 
https://doi.org/10.3889/oamjms.2017.033 
eISSN: 1857-9655 
Basic Science 
 
 
  
 
Leptin and Lipid Profile in Overweight Patient with Type 1 
Diabetes 
 
 
Soha M. Abd El Dayem
1*
, Mona Abd El Kader
2
, Soheir Ibrahim
3
, Enas Mokhtar
1
, Eman Abd El Megeed
4
 
 
1
Pediatrics Department, National Research Centre, Cairo, Egypt; 
2
Clinical Pathology Department, National Research Centre, 
Cairo, Egypt; 
3
Pediatrics Department, Al-Azhar University, Cairo, Egypt; 
4
Pediatrics Department, Cairo, Egypt 
 
Citation: Abd El Dayem SM, Abd El Kader M, Ibrahim S, 
Mokhtar E, Abd El Megeed E. Leptin and Lipid Profile in 
Overweight Patient with Type 1 Diabetes. Open Access 
Maced J Med Sci. 2017 Apr 15; 5(2):131-136. 
https://doi.org/10.3889/oamjms.2017.033 
Keywords: Leptin; lipid profile; overweight; type 1 
diabetic patient. 
*Correspondence: Soha Abd El Dayem. Professor of 
Pediatrics, Consultant of Diabetes and Endocrinology, 
Medical Research Division, National Research Centre, 
Pediatrics Department, Cairo, Egypt. Phone: +2 
01006716852. E-mail: S_eldayem@yahoo.com 
 
Received: 19-Oct-2016; Revised: 21-Jan-2017; 
Accepted: 24-Feb-2017; Online first: 19-Mar-2017 
Copyright: © 2017 Soha M. Abd El Dayem, Mona Abd El 
Kader, Soheir Ibrahim, Enas Mokhtar, Eman Abd El 
Megeed. This is an open-access article distributed under 
the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 
4.0). 
Funding: This research did not receive any financial 
support.
 
Competing Interests: The authors have declared that no 
competing interests exist. 
 
 
 
 
Abstract  
AIM: To evaluate leptin and lipid profile in overweight patients with type 1 diabetes.  
PATIENTS AND METHODS: The study included 50 overweight patients with type 1 diabetes and 50 age and sex 
matched healthy controls. Blood samples were taken for evaluation of glycosylated haemoglobin, lipid profile and 
leptin. Also, urine samples were taken for evaluation of albumin/creatinine ratio.  
RESULTS: Leptin level was significantly lower in overweight with type 1 diabetes and showed a significant 
positive correlation with hip circumference and body mass index and negative correlation with glycosylated 
haemoglobin (HbA1c). Leptin level was significantly lower in overweight diabetic patients with HbA1c > 7.5 %. 
The best cut-off point between overweight diabetic group and control group regarding leptin levels was found at 
16.9 (ng/ml) with a sensitivity of 68% and specificity of 56%, area under the curve 0.623.  
CONCLUSION: Leptin levels were found to be low in overweight patients with type 1 diabetes and showed 
correlation with the body mass index and hip circumference. LDL was significantly higher while HDL was 
significantly lower in the diabetic, overweight group indicating increased risk of cardiovascular disease. Leptin 
level in overweight diabetic patients might be related to the metabolic control. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The incidence of type 1 diabetes is increasing 
3–5% per year worldwide, and this increase is not 
related to genetic factors. A parallel increase in 
childhood obesity has occurred, and as a result, it is 
thought that obesity may be contributing to the 
increasing incidence of type 1 diabetes [1]. Body 
mass index (BMI) measured as weight in kilogrammes 
divided by height in meters squared. Childhood 
obesity, as defined by the American. Medical 
Association expert committee reports two cut-off 
values of 85
th
 and 95
th
 percentiles for BMI-for-age, 
from 85
th
 up to 95
th 
percentile being defined as 
‘‘overweight’’ and BMI-for-age at or above the 95
th
 
percentile, being defined as ‘‘obesity’’ [2].  
Inflammation is a condition that is common to 
both obesity and types 1 diabetes, and systemic 
inflammation is associated with the development of 
micro and macro vascular complications among 
persons with type 1 diabetes. However, the role of 
obesity compared with hyperglycemia in the 
development of inflammation among children with 
type 1 diabetes is unclear [3].  
Leptin is a metabolic protein produced by the 
adipose tissue and both leptin and leptin receptors 
reported to be decreased in individuals with type 1 
diabetes [4]. Leptin control food intake via brain 
signalling of satiety and energy store and is 
paradoxically increased with obesity, obese 
individuals appearing to be resistant to the effects of 
leptin [5]. 
The aim of our study was to evaluate leptin 
and lipid profiles in overweight patients with type 1 
diabetes.  
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Patients and Methods 
 
A cross-sectional observational study was 
performed after obtaining approval from the Ethical 
Committee of the National Research Centre, Cairo, 
Egypt. Written informed consent was obtained from all 
patients, their parents and controls after a full 
discussion about the aim of the study.
 
Fifty overweight children with type 1 diabetes, 
from the Endocrine Unit in the National Research 
Centre and fifty overweight health children without 
type 1 diabetes with age and sex matched were 
included as a comparative group.  
 
Inclusion criteria  
Overweight children (3-18years) with type 1 
diabetes were included.  
 
Exclusion criteria 
Children using glucose-or lipid-lowering 
drugs; children using corticosteroids or drugs acting 
on the central nervous system; children with 
suspected syndromes with type 1 diabetes as Down 
syndrome and type 2 diabetes (T2DM); and children 
with other endocrinal causes of overweight, such as 
hypothyroidism, hypogonadism and pituitary disorders 
were excluded from the study. 
 
 
Results 
 
The study included 50 overweight patients 
with type 1 diabetes (34 females and 16 males), mean 
age of 15.74 ± 3.98 yr (3.5 – 18 yr) and meant 
duration of diabetes 10.01 ± 3.64 yr. The comparison 
between anthropometric and laboratory data of 
overweight diabetic and control group are shown in 
Table 1. 
Table 1: Comparison between anthropometric and laboratory 
data of overweight diabetic and control group  
 
Diabetic group  Control group 
Independent  
t-test 
Mean SD Mean SD t p-value 
Systolic (mmHg) 117.30 14.29 118.20 6.29 0.408 0.685 
Diastolic (mmHg) 75.50 10.06 76.00 5.35 0.310 0.757 
Weight (kg) 67.62 12.05 57.78 9.71 -4.497 0.000 
Height (cm) 158.67 11.31 158.43 14.97 -0.089 0.929 
Waist (circumference) 85.49 9.39 75.73 8.29 5.436 0.0001 
Hip (circumference) 94.84 8.52 91.21 9.08 -2.052 0.043 
Waist/hip (ratio) 0.90 0.06 0.83 0.08 4.665 0.0001 
Waist/height (ratio) 0.54 0.06 0.48 0.05 5.150 0.0001 
BMI (kg/ m2) 27.03 1.78 27.55 1.49 1.582 0.117 
Cholesterol (mg/dl) 180.92±44.47 107 – 287 173.24±33.96 113 – 287 -0.964 0.338 
Triglyceride (mg/dl) 97.32±48.11 29 – 288 91.76 ± 32 45 – 160 -0.676 0.501 
HDL-c (mg/dl) 51.80±25.38 20 – 180 65.48 ± 22.4 50 – 180 2.813 0.006 
LDL-c  (mg/dl) 108.83±33.85 51 – 197 80.49 ± 23.41 25 – 100 -4.599 0.0001 
BMI: Body mass index; Bold indicates significant. 
Leptin levels were significantly lower in the 
group of overweight diabetic patients (Table 2).  
Table 2: Comparison between overweight diabetic control group 
regarding serum leptin level 
 
Diabetic group Control group Mann-Whitney test 
Median (IQR) Median (IQR) Z P-value 
Leptin (ng/ml) 11 (5.2 - 24.8) 18.3 (9.9 - 32.6) 2.127 0.033 
Boldly indicates significant.
 
 
Leptin levels showed significant positive 
correlation with hip circumference and body mass 
index and negative correlation with HbA1c in 
overweight diabetic patients (Table 3).  
Table 3: Correlation between leptin and demographic, 
anthropometric and laboratory data of overweight diabetic 
group 
 
Leptin 
N p-value 
Age (yrs) 0.066 0.648 
Duration of disease (yrs) 0.100 0.488 
Onset of disease (yrs) -0.029 0.841 
Insulin (U/kg) 0.011 0.944 
Systolic blood pressure (mmHg) -0.210 0.142 
Diastolic blood pressure (mmHg) -0.146 0.31 
Weight (kg) 0.044 0.762 
Height (cm) 0.004 0.98 
Waist circumference  0.148 0.311 
Hip circumference  0.320 0.025 
Waist/hip ratio -0.170 0.096 
Waist/height ratio -0.053 0.609 
BMI (kg/m
2
) 0.286 0.044 
HbA1c (%) -0.665 0.0001 
Albumin/ creatinine ratio (µg/g creatinine) -0.015 0.916 
Cholesterol (mg/dl) 0.015 0.919 
Triglyceride (mg/dl) -0.035 0.811 
HDL-c (mg/dl) -0.051 0.728 
LDL-c (mg/dl)  0.112 0.461 
BMI: Body mass index, HbA1c: glycosylated hemoglobin, HDL-c : high density lipoprotein 
cholesterol, LDL-c: Low density lipoprotein cholesterol. Bold indicates significant. 
 
Leptin level was significantly lower in 
overweight diabetic patients with HbA1c > 7.5 % 
(Table 4).  
Table 4: Comparison between leptin levels in overweight 
diabetic group regarding HbA1c 
 Leptin level Mann-Whitney test 
 N Median (IQR) Z p-value 
HbA1c < 7.5 % 11 30.7 (8.2 – 39.1) 
2.513 0.011 
HbA1c > 7.5 % 39 11.0 (5.1 – 17.7) 
Boldly indicates significant.
 
 
There was a significant positive correlation 
between leptin and body mass index of the control 
group as shown in Table 5.  
The correlation between lipid parameters and 
other demographic data in the overweight diabetic 
group are given in Table 6.  
The best cut-off point between overweight 
diabetic group and control group regarding the level of 
leptin was found 16.9 ng/ml with a sensitivity of 68% 
and specificity of 56% and area under the curve of 
0.623.
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Table 5: Correlation between leptin, and demographic, 
anthropometric and laboratory data in the overweight control 
group 
 
Leptin 
N p-value 
Age (yrs) 0.010 0.947 
Weight (kg) 0.010 0.945 
Height (cm) -0.029 0.843 
Systolic (mmHg) 0.050 0.728 
Diastolic (mmHg) 0.004 0.979 
Waist (circumference) -0.223 0.120 
Hip (circumference) -0.157 0.277 
BMI (kg/m
2
) 0.294 0.038 
Waist/hip ratio -0.091 0.528 
Waist/height ratio -0.122 0.398 
Cholesterol (mg/dl) 0.050 0.733 
Triglyceride (mg/dl) -0.014 0.923 
HDL-c (mg/dl) -0.096 0.517 
LDL-c (mg/dl) 0.071 0.648 
BMI: Body mass index, HbA1c: glycosylated hemoglobin, HDL-c: high density lipoprotein 
cholesterol, LDL-c: Low density lipoprotein cholesterol. Bold indicates significant. 
 
 
Discussion 
 
In the present study, we found that the 
median (IQR) serum leptin level was significantly 
lower in the diabetic, overweight group 11 (5.2 - 24.8) 
ng/ml compared to the non-diabetic, overweight group 
18.3 (9.9 - 32.6) ng/ml. It was consistent with the 
findings of Kirel et al., [12], Abd EL- Maksoud et al., 
[13] and Kratzsch et al., [14], who stated that 
decompensation of metabolism in children with newly 
diagnosed type 1 diabetes is associated with changes 
in the leptin axis, with elevated soluble leptin 
receptors and reduced leptin levels. 
 
Table 6: Correlation between lipid profile and other demographic 
data in overweight diabetic group 
 
Cholesterol Triglyceride HDL-c LDL-c 
r 
P-
value 
r 
P-
value 
r 
P-
value 
r 
P-
value 
Age (yrs) 0.006 0.968 -0.172 0.233 0.139 0.339 -0.068 0.642 
Duration of disease  
(yrs) 
-0.054 0.712 0.014 0.924 -0.192 0.187 0.076 0.602 
Onset of disease (yrs) 0.036 0.801 -0.084 0.560 0.229 0.113 -0.170 0.244 
Inslulin dose (U/Kg) -0.007 0.967 0.072 0.650 -0.179 0.263 -0.026 0.871 
Systolic blood pressure 
(mmHg) 
0.052 0.720 0.158 0.274 0.035 0.811 -0.027 0.854 
Diastolic blood pressure  
(mmHg) 
-0.028 0.846 0.078 0.591 -0.301 0.036 0.020 0.893 
Weight (kg) -0.056 0.699 0.070 0.631 -0.278 0.053 0.106 0.470 
Height (cm) -0.132 0.360 -0.021 0.884 -0.438 0.002 0.132 0.368 
Waist circumference (cm) 0.081 0.578 0.059 0.688 -0.097 0.511 0.219 0.134 
Hip circumference (cm) -0.029 0.845 -0.072 0.621 -0.223 0.127 0.195 0.185 
BMI (kg/m2)  0.058 0.688 0.121 0.403 0.024 0.870 0.234 0.105 
HbA1c (%) 0.214 0.139 0.170 0.242 0.073 0.620 0.270 0.063 
BMI: Body mass index, HbA1: glycosylated hemoglobin, HDL-c: high density lipoprotein 
cholesterol, LDL-c: Low density lipoprotein cholesterol. Bold indicates significant. 
 
The molar excess of soluble leptin receptors 
over leptin in this condition may contribute to leptin 
insensitivity. Also, the diminished leptin concentrations 
in patients with newly diagnosed type 1 diabetes could 
be caused by insulin deficiency and increased 
lipolysis [15]. 
Soliman et al., [16] and Snell-Bergeon et al., 
[17] suggested that leptin is lower in newly diagnosed 
patients with type 1 diabetes than in children with 
longer disease duration, perhaps related to 
differences in peripheral insulin levels and fat mass. 
Table 7: Receiver operating characteristic curve for the cut-off 
point of leptin between the overweight diabetic group and control 
group 
Cut off 
point 
AUC Sensitivity Specificity PPV NPV 
<16.9 ng/ml 0.623 68.00 56.00 60.7 63.6 
AUC: Area under the curve, PPV: Positive  predictive value, NPV: Negative predictive value.   
 
In the present study, we reported that there 
was a statistically significant positive correlation 
between the mean serum leptin levels and BMI in the 
diabetic, overweight group and the non-diabetic, 
overweight group and this was by Al Maskari et al., 
[18] and Abd EL-Maksoud et al., [13]. Nishimura et al., 
[19] also revealed that serum leptin levels in school 
children aged from 9-13 years were positively 
correlated with the body mass index, irrespective of 
age or gender. Another study by Antunes et al., [20] of 
overweight children with mean age of 9.5 years 
showed that BMI and gender were determinant.factors 
of leptin levels [21].  
Type 1 diabetics have a high risk of 
cardiovascular disease (CVD), and premature 
atherosclerosis represents the main cause of 
morbidity and mortality in diabetic populations [22]. 
Many types of research revealed that atherosclerosis 
begins early in life and therefore, determination and 
preventive strategies of risk factors for CVD should be 
started during childhood and adolescence [23]. Type 1 
diabetic children and adolescents are a high-risk 
population with regards to CVD, given that 
cardiovascular risk factors are common among them 
[23-25] leading to poor long-term prognosis [26]. It has 
been shown that as many as 86% of youth with type 1 
diabetes have at least one, 45% at least two and 15% 
at least three CVD risk factors, including high HbA1c, 
high blood pressure, dyslipidemia, smoking and family 
history of CVD events [24]. High incidence of 
dyslipidemia has often been reported in patients with 
type1 diabetes up to 58% of type 1 diabetics were 
found to be hyperlipidemic [27, 28]. 
In the present study, we found that the HDL 
was statistically significantly lower and LDL was 
significantly higher in the diabetic, overweight group. 
Also, triglycerides and total cholesterol levels were 
high in the diabetic, overweight group.
 
Salem et al., [29] conducted a study on type 1 
diabetic patients with mean age of 15.93 ± 1.99 years 
and showed that dyslipidemia was prevalent in those 
patients where triglycerides, total cholesterol and LDL 
cholesterol were significantly higher while HDL 
cholesterol was decreased compared with controls. 
Therefore, we should evaluate lipids soon after 
diagnosis in type 1 diabetic children aged more than 
12 years, and it should be repeated every five years if 
normal results are obtained. Statins should be started 
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if interventions to improve metabolic control and 
dietary changes could not help to reach the target 
level [30]. 
This finding is in agreement with Gunczler et 
al., [31] who found that TC, LDL-C and Tg levels were 
elevated in 34.4%, 25.0% and 15.6% of the 
adolescents with type 1 diabetes respectively 
compared with 20.0%, 13.3% and 6.7% of the control 
subjects. 
Snell-Bergeon et al., [17] reported an increase 
in total and LDL-cholesterol as well as increased apo 
B. Also, higher levels of IL-6 were associated with 
lower levels of HDL-cholesterol. These results showed 
that systemic inflammation is high in type 1 diabetics, 
irrespective to hyperglycemia and obesity and it is 
associated with a more atherogenic lipid profile, 
putting these youth at higher risk of cardiovascular 
disease. 
 
Hassan et al., [32] found that the most 
frequent type of dyslipidemia was high LDL-C and low 
HDL-C in 28.2% of the children and adolescents with 
type 1 diabetes and dyslipidemia, while high LDL-C 
and hypercholesterolemia with and without 
hypertriglyceridemia were found to be the most 
common types in Al-Naama et al., [33] and Rahma et 
al., [34]. The diabetic children in the previous two 
studies showed poor high-risk glycemic control 
according to the mean fasting blood glucose (FBG) 
(232.0 ± 92.0 mg/dl) and HbA1c (9.8 ± 4.2%) levels. 
 
Herman et al., [35] and Kantoosh et al., [36] 
reported that in Egyptian diabetic children, 
hypertriglyceridemia was the predominant type and 
reported significantly higher serum Tg and HbA1c 
levels in the untreated newly diagnosed children with 
type 1 diabetes in comparison to the treated diabetics 
with good glycemic control. Patiakas et al., [37] found 
that hypercholesterolemia was the most frequent type, 
and hypertriglyceridemia is the least frequent type in 
diabetic patients in contrast to Already et al., [38] who 
reported that high triglyceride is a common pattern of 
dyslipidemia in type 1 diabetics children and 
adolescents.and it is related to different levels of 
glycemic controls. 
In the present work, no significant correlation 
was found between the duration of disease and lipid 
abnormalities in the diabetic, overweight group. This 
finding in agreement with Maahs et al., [39] who found 
that there was no relationship between the lipid 
abnormalities in paediatric type 1 diabetes and the 
duration of diabetes. 
 
Hamad and Qureshi [40], Guy et al., [41] and 
Kanagalakshmi and Sultana (42) found that 
dyslipidemia in children and adolescents with type 1 
diabetes is present despite the short duration of 
diabetes. This is in contrast to the results reported by 
Moayeri and Oloomi [43] who found that lipid 
concentrations correlate positively with the duration of 
diabetes. Also, Schwab et al., [44] stated that 
atherogenic risk factors as dyslipidemia in children 
and adolescents with type 1 diabetes are related to 
the longer duration of diabetes. 
In our study, there was no statistical 
difference in the mean age, gender and the lipid 
abnormalities. This finding in agreement with Alrabaty 
et al., [38] and Patiakas et al., [37]. They reported that 
there was no relationship between gender and lipid 
abnormalities in type 1 diabetic children and 
adolescents. Also Ladeia et al., [45], Maahs et al., [39] 
and Wiltshire et al., [46], found no significant 
correlation between age and serum LDL-C of the 
patients with diabetes. 
This finding is in contrast to the results 
reported by Krantz et al., [47] and Schwab et al., [44] 
who found that lipid levels were significantly higher in 
female subjects compared with male subjects with 
type 1 diabetes. However, no significant difference of 
HDL-C was found between female and male subjects 
by Schwab et al., [44]. Moayeri and Oloomi [43] found 
that the higher mean age of children and adolescents 
with T1DM is associated with more frequent 
dyslipidemia. 
In our study, we found that there was 
statistically significant lower median leptin level in the 
diabetic, overweight subgroup with HbA1c > 7.5. Our 
findings were consistent with a study done by Snell-
Bergeon et al., [17] and Abd El- Maksoud et al., [13], 
who showed that the leptin levels were lowest among 
patients with higher HbA1c.  
Al-Suhaimi et al., [48] stated that there was a 
positive significant correlation of leptin with HbA1c. 
However, they explained this correlation by the finding 
of Soliman et al., [16] who reported that over 
substitution by insulin exerted many metabolic actions 
contributing to the elevation of leptin release. They 
attributed the higher leptin levels glycemic control to 
type 1 children with diabetes (higher circulating HbA1c 
concentrations that those treated with insulin).
 
Regarding mean HbA1c values, we observed 
no significant correlations between HbA1c and serum 
TC, TG and LDL-C; this result is in concordance with 
Muchacka-Bianga et al., [49] and Kantoosh et al., [36] 
who found that lipid disorders in children with T1DM 
may be present regardless of their metabolic control. 
On the contrary, Teles and Fornés [50] and Guy et al., 
[41] found that poorer (inadequate) glycemic control is 
related to higher serum lipids levels. Ladeia et al., [45] 
and Krantz et al., [47] found significant correlations 
between glycemic control and lipid levels. 
In our study, ROC curve analysis revealed 
that the cutoff point between the diabetic, overweight 
group and non-diabetic, overweight group regarding 
the level of leptin was found at 16.9 ng/ml with a 
sensitivity of 68% and specificity of 56%. Type 1 
diabetic patients with levels above this cut-off may 
have a higher risk of developing complications and 
should be closely followed up. However, to the best of 
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our knowledge, no previous studies assessed leptin 
cut off in type 1 diabetes and therefore, further 
prospective studies are needed to validate these 
thresholds.
 
In conclusion, low leptin levels were observed 
in overweight diabetic patients and were shown to be 
correlated to body mass index and hip circumference. 
LDL was statistically significantly higher while HDL 
was significantly lower in the diabetic, overweight 
group indicating increased risk of cardiovascular 
disease. Leptin level in overweight diabetic patients 
may be related to metabolic control.
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